Global Meningococcal Vaccine Market Research Report 2022 Professional Edition

  • Published Date : 04-04-2022
  • Pages : 123
  • Report Id : 62310
  • Categories : Healthcare

The global Meningococcal Vaccine market was valued at 230.87 Million USD in 2022 and will grow with a CAGR of 4.33% from 2022 to 2028, based on Research Allied newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
By Market Verdors:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

By Types:
Quadrivalent
Bivalent

By Applications:
Pneumonia
Meningitis
Bacteremia

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Meningococcal Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Meningococcal Vaccine Market Size Growth Rate by Type: 2022 VS 2028
1.4.2 Quadrivalent
1.4.3 Bivalent
1.5 Market by Application
1.5.1 Global Meningococcal Vaccine Market Share by Application: 2017-2028
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Meningococcal Vaccine Market
1.8.1 Global Meningococcal Vaccine Market Status and Outlook (2017-2028)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Meningococcal Vaccine Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Meningococcal Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Meningococcal Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Meningococcal Vaccine Sales Volume Market Share by Region (2017-2022)
3.2 Global Meningococcal Vaccine Sales Revenue Market Share by Region (2017-2022)
3.3 North America Meningococcal Vaccine Sales Volume
3.3.1 North America Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.3.2 North America Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 East Asia Meningococcal Vaccine Sales Volume
3.4.1 East Asia Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.4.2 East Asia Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Meningococcal Vaccine Sales Volume (2017-2022)
3.5.1 Europe Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.5.2 Europe Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 South Asia Meningococcal Vaccine Sales Volume (2017-2022)
3.6.1 South Asia Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.6.2 South Asia Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Southeast Asia Meningococcal Vaccine Sales Volume (2017-2022)
3.7.1 Southeast Asia Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.7.2 Southeast Asia Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 Middle East Meningococcal Vaccine Sales Volume (2017-2022)
3.8.1 Middle East Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.8.2 Middle East Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.9 Africa Meningococcal Vaccine Sales Volume (2017-2022)
3.9.1 Africa Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.9.2 Africa Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.10 Oceania Meningococcal Vaccine Sales Volume (2017-2022)
3.10.1 Oceania Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.10.2 Oceania Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.11 South America Meningococcal Vaccine Sales Volume (2017-2022)
3.11.1 South America Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.11.2 South America Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.12 Rest of the World Meningococcal Vaccine Sales Volume (2017-2022)
3.12.1 Rest of the World Meningococcal Vaccine Sales Volume Growth Rate (2017-2022)
3.12.2 Rest of the World Meningococcal Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
4 North America
4.1 North America Meningococcal Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Meningococcal Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Meningococcal Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Meningococcal Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Meningococcal Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Meningococcal Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Meningococcal Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Meningococcal Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Meningococcal Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Meningococcal Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Meningococcal Vaccine Sales Volume Market Share by Type (2017-2022)
14.2 Global Meningococcal Vaccine Sales Revenue Market Share by Type (2017-2022)
14.3 Global Meningococcal Vaccine Sales Price by Type (2017-2022)
15 Consumption Analysis by Application
15.1 Global Meningococcal Vaccine Consumption Volume by Application (2017-2022)
15.2 Global Meningococcal Vaccine Consumption Value by Application (2017-2022)
16 Company Profiles and Key Figures in Meningococcal Vaccine Business
16.1 Novartis
16.1.1 Novartis Company Profile
16.1.2 Novartis Meningococcal Vaccine Product Specification
16.1.3 Novartis Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.2 GSK
16.2.1 GSK Company Profile
16.2.2 GSK Meningococcal Vaccine Product Specification
16.2.3 GSK Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.3 Merck
16.3.1 Merck Company Profile
16.3.2 Merck Meningococcal Vaccine Product Specification
16.3.3 Merck Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.4 CSL
16.4.1 CSL Company Profile
16.4.2 CSL Meningococcal Vaccine Product Specification
16.4.3 CSL Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.5 Baxter
16.5.1 Baxter Company Profile
16.5.2 Baxter Meningococcal Vaccine Product Specification
16.5.3 Baxter Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.6 JN International Medical Corporation
16.6.1 JN International Medical Corporation Company Profile
16.6.2 JN International Medical Corporation Meningococcal Vaccine Product Specification
16.6.3 JN International Medical Corporation Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.7 Serum Institute of India
16.7.1 Serum Institute of India Company Profile
16.7.2 Serum Institute of India Meningococcal Vaccine Product Specification
16.7.3 Serum Institute of India Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.8 Bio-Med
16.8.1 Bio-Med Company Profile
16.8.2 Bio-Med Meningococcal Vaccine Product Specification
16.8.3 Bio-Med Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.9 China National Biotec Group
16.9.1 China National Biotec Group Company Profile
16.9.2 China National Biotec Group Meningococcal Vaccine Product Specification
16.9.3 China National Biotec Group Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.10 Hualan Bio
16.10.1 Hualan Bio Company Profile
16.10.2 Hualan Bio Meningococcal Vaccine Product Specification
16.10.3 Hualan Bio Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.11 Walvax
16.11.1 Walvax Company Profile
16.11.2 Walvax Meningococcal Vaccine Product Specification
16.11.3 Walvax Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.12 Zhifei
16.12.1 Zhifei Company Profile
16.12.2 Zhifei Meningococcal Vaccine Product Specification
16.12.3 Zhifei Meningococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2017-2022)
17 Meningococcal Vaccine Manufacturing Cost Analysis
17.1 Meningococcal Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Meningococcal Vaccine
17.4 Meningococcal Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Meningococcal Vaccine Distributors List
18.3 Meningococcal Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Meningococcal Vaccine (2017-2028)
20.2 Global Forecasted Revenue of Meningococcal Vaccine (2017-2028)
20.3 Global Forecasted Price of Meningococcal Vaccine (2017-2028)
20.4 Global Forecasted Production of Meningococcal Vaccine by Region (2017-2028)
20.4.1 North America Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.2 East Asia Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.3 Europe Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.4 South Asia Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.5 Southeast Asia Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.6 Middle East Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.7 Africa Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.8 Oceania Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.9 South America Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.4.10 Rest of the World Meningococcal Vaccine Production, Revenue Forecast (2017-2028)
20.5 Forecast by Type and by Application (2017-2028)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2017-2028)
20.5.2 Global Forecasted Consumption of Meningococcal Vaccine by Application (2017-2028)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Meningococcal Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Meningococcal Vaccine by Country
21.3 Europe Market Forecasted Consumption of Meningococcal Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Meningococcal Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Meningococcal Vaccine by Country
21.6 Middle East Forecasted Consumption of Meningococcal Vaccine by Country
21.7 Africa Forecasted Consumption of Meningococcal Vaccine by Country
21.8 Oceania Forecasted Consumption of Meningococcal Vaccine by Country
21.9 South America Forecasted Consumption of Meningococcal Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Meningococcal Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Research Allied Copyright © 2022 .